Showing results (471-480 of 631) with videos related to
Sort By:
Pageof 64
Thrombosis and Haemostasis|March 4, 1991
Fibrinolysis and coagulation in patients with infectious disease and sepsisJ Philippé, F Offner, P J Declerck, et al.The Journal of Biological Chemistry|April 15, 1993
On the mechanism of the activation of human plasminogen by recombinant staphylokinaseD Collen, B Schlott, Y Engelborghs, et al.The Journal of Biological Chemistry|September 25, 1989
Characterization of the binding of human tissue-type plasminogen activator to plateletsD E Vaughan, M E Mendelsohn, P J Declerck, et al.Circulation|April 1, 1987
Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprololF Van de Werf, J Vanhaecke, I K Jang, et al.Diabetologia|April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal diseaseM Lassila, K Fukami, K Jandeleit-Dahm, et al.Nature Medicine|January 3, 2001
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signalingO Nicole, F Docagne, C Ali, et al.Development (Cambridge, England)|April 6, 2001
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defectsY Dor, T D Camenisch, A Itin, et al.Nature Medicine|July 4, 2001
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopyE B Brown, R B Campbell, Y Tsuzuki, et al.Cell|July 31, 1999
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesisP Carmeliet, M G Lampugnani, L Moons, et al.Blood|January 29, 2000
Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinaseS Vanwetswinkel, S Plaisance, Z Zhi-Yong, et al.Pageof 64